ASSOCIATION BETWEEN INFLAMMATORY - METABOLIC INDEX AND RENAL FUNCTION IN TYPE 2 DIABETES MELLITUS PATIENTS: THE ROLE OF OVERWEIGHT AND OBESITY
Main Article Content
Abstract
Objectives: To investigate the association between monocyte to HDL-C ratio and renal function in patients with type 2 diabetes mellitus, with particular emphasis on overweight and obese individuals.
Subjects and methods: This cross-sectional study included 262 patients diagnosed with type 2 diabetes mellitus who attended the Outpatient Department of University Medical Center Ho Chi Minh City - Campus 2. Patients were stratified according to BMI (< 25 kg/m² and ≥ 25 kg/m²) for subgroup analysis.
Results: Among patients with BMI ≥ 25 kg/m², monocyte to HDL-C ratio values were significantly higher and monocyte to HDL-C ratio was negatively correlated with eGFR (r = -0.28, p = 0.0063) and positively correlated with UACR (r = 0.24, p = 0.0208). In this subgroup, multivariable regression analysis demonstrated that monocyte to HDL-C ratio was an independent predictor of eGFR decline after adjustment for age and hemoglobin (p < 0.001) and predicted eGFR < 60 mL/min/1.73 m², with an area under the receiver operating characteristic curve of 0.8084.
Conclusions: Monocyte to HDL-C ratio is independently associated with impaired renal function in patients with type 2 diabetes mellitus. These findings suggest that monocyte to HDL-C ratio may serve as a simple and reliable inflammatory - metabolic marker for early identification of chronic kidney disease risk in clinical practice, particularly among overweight and obese patients.
Article Details
Keywords
Monocyte to HDL-C ratio (MHR), renal impairment, overweight, obesity, type 2 diabetes mellitus.
References
[2] Yu H, Yang C et al. The association between mono-cyte-to-high-density lipoprotein cholesterol ratio and type 2 diabetes mellitus: a cross-sectional study. Front Med (Lausanne), 2025, 12: 1521342. doi: 10.3389/fmed.2025.1521342.
[3] Elsayed N.A, Aleppo G et al. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care, 2023, 46 (Suppl 1): S19-40. doi: 10.2337/dc23-S002.
[4] Basha S.Y.C, Sarala M, Devara D.T, Prasad M. A cross-sectional comparative study of the monocyte to high-density lipoprotein cholesterol ratio in normal individu-als, type 2 diabetes mellitus, and diabetic nephropathy. Student’s Journal of Health Research Africa, 2025, 6 (6): 1-8.
[5] Stevens P.E, Ahmed S.B, Carrero J.J, Foster B, Francis A, Hall R.K et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int, 2024, 105 (4): S117-S314.
[6] Obesity: prevent-ing and managing the global epidemic: report of a WHO consultation. World Health Or-ganization, 2000, 894: i-xii, 1-253.
[7] Soesilo N, Hendrianingtyas M, Rachma D.E, Kurnia E, Limijadi S. Monocyte to HDL cholesterol ratio (MHR) and monocyte to lymphocyte ratio (MLR) in overweight and obese women. Modern Medicine, 2023, 30 (4): 335-339. doi: 10.31689/rmm.2023.30.4.335
[8] Kawai T, Autieri M.V, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol, 2021, 320 (3): C375-C391. doi: 10.1152/ajpcell.00379.2020.
[9] Xu L, Li D et al. The association between monocyte to high-density lipoprotein cholesterol ratio and chronic kidney disease in a Chinese adult population: a cross-sectional study. Ren Fail, 2024, 46 (1): 2331614. doi: 10.1080/0886022X.2024.2331614.
[10] Efe F.K. The association between monocyte HDL ratio and albuminuria in diabetic nephropathy. Pak J Med Sci. 2021, 37 (4): 1128-1132. doi: 10.12669/pjms.37.4.3882